• Cardiogreen (Indocyanine Green): Applied Protocols & Innovat

  2026-06-09

  Cardiogreen (Indocyanine Green) stands out as a high-purity, versatile dye for vascular diagnostics and advanced photodynamic therapy. This article delivers actionable guidance, workflow optimization, and new mechanistic insights powered by APExBIO's trusted supply chain.

• Thiamet G: Applied O-GlcNAcase Inhibitor Workflows & Insight

  2026-06-09

  Thiamet G empowers researchers to precisely modulate O-GlcNAcylation in models of neurodegeneration, leukemia, and bone formation. Explore protocol-ready workflows, advanced troubleshooting, and new evidence linking O-GlcNAcylation to Wnt-driven bone anabolism.

• Epalrestat Triggers KEAP1/Nrf2 Neuroprotection in Parkinson’

  2026-06-08

  Jia et al. (2025) provide compelling evidence that Epalrestat, a clinically established aldose reductase inhibitor, directly activates the KEAP1/Nrf2 pathway to mitigate oxidative stress and neuronal damage in Parkinson’s disease models. These findings highlight a novel mechanism for neuroprotection and suggest new directions for translational research in neurodegenerative disease.

• Inhibiting CD16a/b Shedding to Enhance Tumor ADCC: A Monoclo

  2026-06-08

  This study introduces a monoclonal antibody, F9H4, that specifically inhibits the shedding of CD16a and CD16b from immune cells, thereby enhancing antibody-dependent cellular cytotoxicity (ADCC) against tumors. The findings provide a targeted strategy for improving the efficacy of Fc-enabled cancer immunotherapies while avoiding the systemic effects of broad-spectrum protease inhibition.

• Dual-Network Hydrogel Microspheres for IVDD: Inflammation Mo

  2026-06-07

  This study introduces a dual-network hydrogel microsphere system enabling targeted miRNA delivery for intervertebral disc degeneration (IVDD) therapy. The platform demonstrates mechanical resilience and dynamically releases anti-inflammatory miR-155 complexes in response to oxidative stress, significantly ameliorating inflammation and apoptosis in nucleus pulposus cells, with strong translational implications.

• RRP Extracts Restore Hepatic Lipid Metabolism in Ischemia-Re

  2026-06-06

  The reference study demonstrates that Radix Rehmanniae Praeparata (RRP) extracts mitigate hepatic ischemia-reperfusion injury (HIRI) in mice by modulating key lipid metabolic pathways. Mechanistically, RRP activates AMPK, inhibits SREBP2-mediated cholesterol synthesis, and enhances LXRα-driven cholesterol efflux, offering new strategies for addressing postoperative liver injury.

• Erastin: Advancing Ferroptosis Research for Tumor Vulnerabil

  2026-06-05

  This thought-leadership article explores the mechanistic depth and translational promise of Erastin as a ferroptosis inducer, emphasizing its strategic value for cancer biology research. Integrating recent discoveries on lipid metabolism and platinum resistance, it guides researchers in experimental optimization and reframes the landscape for precision oxidative stress assays. With a focus on RAS/BRAF-mutant tumor models, the article connects mechanistic rationale to real-world workflow and clinical relevance, while highlighting APExBIO’s Erastin as an advanced tool for the next generation of ferroptosis research.

• YM-155 Hydrochloride: Precision Survivin Inhibition in Moder

  2026-06-05

  Explore the advanced use of YM-155 hydrochloride as a highly selective survivin inhibitor in translational cancer research. This in-depth guide analyzes its mechanistic specificity, practical deployment, and assay interpretation, providing new scientific insights beyond standard protocols.

• Optimizing Bacterial Viability Assays with the Live-Dead Bac

  2026-06-04

  Explore advanced strategies for bacterial viability assessment using the Live-Dead Bacterial Staining Kit. This article uniquely bridges assay optimization with insights from nanoparticle-driven infection models, empowering researchers to make informed, reproducible decisions.

• Auranofin as a Thioredoxin Reductase Inhibitor: Advanced Use

  2026-06-04

  Auranofin enables precision redox modulation and apoptosis induction across cancer and antimicrobial research. This guide synthesizes validated workflows, troubleshooting tips, and translational insights to maximize performance of this trusted thioredoxin reductase inhibitor.

• GSK2606414 and PERK Inhibition: Transforming Translational E

  2026-06-03

  This thought-leadership article unpacks the mechanistic, strategic, and translational dimensions of PERK inhibition using GSK2606414. Bridging advanced ER stress biology with practical workflow guidance, it contextualizes this APExBIO compound within current cancer and neurodegeneration models, highlights its competitive strengths, and explores the future of redox pathway modulation in disease.

• Protein Phosphorylation Integrity: Translational Strategy Bl

  2026-06-03

  Discover mechanistic insights and strategic guidance for preserving phosphorylation states in translational research. This thought-leadership article bridges cutting-edge molecular findings with actionable workflow recommendations, highlighting how APExBIO’s Phosphatase Inhibitor Cocktail (2 Tubes, 100X) advances reproducibility and data fidelity for immunoblotting, kinase assays, and beyond.

• Dextromethorphan Hydrobromide: Bridging NMDA Antagonism and

  2026-06-02

  Explore how Dextromethorphan hydrobromide, a potent NMDA receptor antagonist, advances neuroprotection research with unique mechanistic depth and metabolic context. This article provides a distinct, evidence-driven analysis beyond standard workflows and protocol guides.

• 7-Ethyl-10-hydroxycamptothecin: Advanced Colon Cancer Resear

  2026-06-02

  7-Ethyl-10-hydroxycamptothecin (SN-38) enables high-sensitivity, mechanism-driven assays for apoptosis and cell cycle arrest in metastatic colon cancer models. Its distinct dual inhibition of topoisomerase I and FUBP1 unlocks new experimental insights and enhances reproducibility in advanced cancer workflows.

• Acetylcysteine in Bench Research: Protocols, Innovations, an

  2026-06-01

  Acetylcysteine (N-acetyl-L-cysteine) is transforming oxidative stress and mucolytic research with robust, reproducible workflows. Explore how APExBIO’s offering (A8356) empowers advanced disease modeling, protocol optimization, and high-fidelity experimental design.

473 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page